HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasic, M. Articles by Turina, M. Search for Related Content PubMed PubMed Citation Articles by Pasic, M. Articles by Turina, M.

European Journal of Cardio-Thoracic Surgery, Vol 6, 149-154, Copyright © 1992 by European Association for Cardio-thoracic Surgery

ARTICLES

Surgical treatment of cardiovascular complications in Marfan syndrome: a 27-year experience

M Pasic, L von Segesser, T Carrel, A Laske, E Bauer and M Turina
Clinic for Cardiovascular Surgery, University Hospital Zurich, Switzerland.

Fifty-two patients with Marfan syndrome and ascending aortic pathology were treated surgically between 1964 and 1990. The indication for primary operation was true aneurysm of the ascending aorta with or without aortic insufficiency in 35 patients (67%) and dissection in 17 (33%). Composite grafts were used in 28 patients (54%; group I) and other procedures on the ascending aorta in 24 patients (46%; group II). The latter included supracoronary graft replacement with or without aortic valve replacement or reconstruction (n = 13), and reconstruction of the ascending aorta with or without aortic valve replacement (n = 11). Composite graft insertion was combined with mitral valve surgery at the same operation in 3 patients (6%). The early mortality after primary operations was 7.7% (4 deaths) and the late mortality was 27% (14 deaths). Eight late deaths were related to cardiovascular complications. The mean follow-up was 6.7 years (range 1-27 years). The actuarial 5-, 10-, and 15-year survival rates for all patients were 82%, 63%, and 44%, respectively; for group I (composite grafts) they were 87%, 76%, and 57%; and for group II (other types of operations) they were 73%, 53%, and 37%. The incidence of late complications was much higher in group II than in group I (50% vs. 16%). At 5 and 10 years, the actuarial rates of freedom from late complications related to the primary operation were 88% and 80%, respectively, in group I and 65% and 18% in group II. Composite graft insertion is the operation of choice when approaching the ascending aorta and/or aortic valve in Marfan syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				T. Carrel, L. Beyeler, A. Schnyder, P. Zurmuhle, P. Berdat, J. Schmidli, and F. S. Eckstein Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 671 - 675. [Abstract] [Full Text] [PDF]

				C. Detter, H. Mair, H.-G. Klein, C. Georgescu, A. Welz, and B. Reichart Long-term prognosis of surgically-treated aortic aneurysms and dissections in patients with and without Marfan syndrome Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 416 - 423. [Abstract] [Full Text] [PDF]

				T. Carrel Conservative Surgical Management of Annulo-Aortic Dilatation Ann. Thorac. Surg., April 1, 1995; 59 (4): 1038 - 1039. [Full Text]